These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 2446801)
1. The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction. Nattel S; Davies M; Quantz M Circulation; 1988 Jan; 77(1):200-8. PubMed ID: 2446801 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion. Somani P; Simon VA; McManus K Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764 [TBL] [Abstract][Full Text] [Related]
3. Concentration response relationships of amiodarone and desethylamiodarone. Connolly SJ; Gupta RN; Hoffert D; Roberts RS Am Heart J; 1988 Jun; 115(6):1208-13. PubMed ID: 3376838 [TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic effects of desethylamiodarone in dogs with subacute myocardial infarction and inducible ventricular arrhythmias. Abdollah H; Brien JF; Brennan FJ J Cardiovasc Pharmacol; 1989 Jan; 13(1):37-44. PubMed ID: 2468934 [TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic effect of chronic oral amiodarone treatment in dogs with myocardial infarction and reproducibly inducible sustained ventricular arrhythmias. Abdollah H; Brien JF; Brennan FJ J Cardiovasc Pharmacol; 1990 May; 15(5):799-807. PubMed ID: 1692941 [TBL] [Abstract][Full Text] [Related]
6. Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat. Riva E; Hearse DJ Cardiovasc Res; 1989 Apr; 23(4):331-9. PubMed ID: 2590914 [TBL] [Abstract][Full Text] [Related]
7. Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite. Talajic M; DeRoode MR; Nattel S Circulation; 1987 Jan; 75(1):265-71. PubMed ID: 3791608 [TBL] [Abstract][Full Text] [Related]
8. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations. Escoubet B; Coumel P; Poirier JM; Maison-Blanche P; Jaillon P; Leclercq JF; Menasche P; Cheymol G; Piwnica A; Lagier G Am J Cardiol; 1985 Mar; 55(6):696-702. PubMed ID: 3976511 [TBL] [Abstract][Full Text] [Related]
9. Relationship between myocardial amiodarone concentration and antiarrhythmic effect in dogs with myocardial infarction and electrically induced ventricular arrhythmias. Abdollah H; Brennan FJ; Jimmo S; Brien JF Can J Physiol Pharmacol; 1991 Jun; 69(6):812-7. PubMed ID: 1913327 [TBL] [Abstract][Full Text] [Related]
10. Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects. Falik R; Flores BT; Shaw L; Gibson GA; Josephson ME; Marchlinski FE Am J Med; 1987 Jun; 82(6):1102-8. PubMed ID: 3605129 [TBL] [Abstract][Full Text] [Related]
11. Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats. Morvay N; Baczkó I; Sztojkov-Ivanov A; Falkay G; Papp JG; Varró A; Leprán I Can J Physiol Pharmacol; 2015 Sep; 93(9):773-7. PubMed ID: 26176275 [TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite. Nattel S J Cardiovasc Pharmacol; 1986; 8(4):771-7. PubMed ID: 2427817 [TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs. Nagasawa Y; Chen J; Hashimoto K J Pharmacol Sci; 2005 Mar; 97(3):393-9. PubMed ID: 15764841 [TBL] [Abstract][Full Text] [Related]
14. Amiodarone- and desethylamiodarone-induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes. Somani P; Bandyopadhyay S; Klaunig JE; Gross SA Hepatology; 1990 Jan; 11(1):81-92. PubMed ID: 2153095 [TBL] [Abstract][Full Text] [Related]
15. Distribution of amiodarone and desethylamiodarone in a patient with acute myocardial infarction after intravenous administration. Barbieri E; Latini R; D'Aranno V; Fabbri A; Zampieri P; Trevi GP; Zardini P Clin Cardiol; 1987 Nov; 10(11):674-6. PubMed ID: 3677501 [TBL] [Abstract][Full Text] [Related]
16. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens. Brien JF; Jimmo S; Brennan FJ; Armstrong PW; Abdollah H Drug Metab Dispos; 1990; 18(6):846-51. PubMed ID: 1981527 [TBL] [Abstract][Full Text] [Related]
17. [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels]. Nitsch J; Lüderitz B Dtsch Med Wochenschr; 1984 Mar; 109(13):492-5. PubMed ID: 6423357 [TBL] [Abstract][Full Text] [Related]
18. Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure. Candinas R; Frielingsdorf J; Ha HR; Carrel T; Turina M; Follath F Eur J Clin Pharmacol; 1998 Jan; 53(5):331-6. PubMed ID: 9516032 [TBL] [Abstract][Full Text] [Related]